All products are supplied for laboratory research use only — not for human or veterinary use.

Peptide Medix · Research catalog
Ascend Stack (Semaglutide · Cagrilintide · Lipo-C vials) — Lyophilized powder for the peptides; Lipo-C supplied as a liquid
  • ≥99% by HPLC on both peptides; lot-matched COA for each
  • Lot-matched certificate of analysis
  • Ships next business day, tracked

Weight Management Blends

Ascend Stack (Semaglutide · Cagrilintide · Lipo-C vials)

Three-vial metabolic kit pairing semaglutide and cagrilintide with a Lipo-C solution

In stock·1 format available
$153
Choose a format
Ask about this listing or request its COA
  • FormLyophilized powder for the peptides; Lipo-C supplied as a liquid
  • Research areasIncretin and amylin receptor signalling, lipid metabolism, energy balance models

Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.

Overview

The Ascend Stack combines two long-acting metabolic peptides with a lipotropic compounded solution, supplied as three separate vials. It is the only kit in this range that mixes formats: semaglutide and cagrilintide arrive as lyophilized powders requiring reconstitution, while Lipo-C is supplied as a ready-made liquid.

Semaglutide is an acylated GLP-1 receptor agonist carrying an aminoisobutyric acid substitution at position 8 to resist DPP-4 cleavage and a C18 fatty diacid side chain that binds serum albumin. Cagrilintide is a long-acting analogue of amylin, the pancreatic hormone co-secreted with insulin, engineered for solubility and stability where native amylin aggregates readily. Lipo-C is not a peptide at all: it is a lipotropic solution combining methionine, inositol and choline with cyanocobalamin and L-carnitine, and it is characterised as a formulation rather than by a single molecular weight or CAS number.

The two peptides are HPLC-assayed to ≥99% purity with individual lot-matched certificates of analysis; the Lipo-C solution is released against its own formulation specification. Because one component is a liquid and two are powders, separate supply is the only sensible format. Research use only.

Specifications

Supply & purity

Form
Lyophilized powder for the peptides; Lipo-C supplied as a liquid
Purity
≥99% by HPLC on both peptides; lot-matched COA for each

Additional detail

Product type
Multi-vial research kit — two lyophilized peptides plus one solution
Kit contents
One semaglutide vial, one cagrilintide vial, one Lipo-C solution vial
Semaglutide
CAS 910463-68-2 · C187H291N45O59 · 4113.58 g/mol
Cagrilintide
CAS 1415456-99-3 · C194H309N55O59S2 · 4409.07 g/mol
Lipo-C composition
Methionine, inositol and choline with cyanocobalamin and L-carnitine
Semaglutide class
Acylated GLP-1 receptor agonist, Aib substitution at position 8
Cagrilintide class
Long-acting amylin and calcitonin receptor agonist, 32 residues
Research areas
Incretin and amylin receptor signalling, lipid metabolism, energy balance models
Reconstitution
Peptide vials prepared separately; Lipo-C requires no reconstitution
Storage (lyophilized peptides)
−20 °C, protected from light and moisture
Storage (Lipo-C solution)
2–8 °C, protected from light

Questions about Ascend Stack (Semaglutide · Cagrilintide · Lipo-C vials)

Why is one component supplied as a liquid?

Lipo-C is a compounded lipotropic solution rather than a lyophilized peptide, so it ships ready to use. The two peptides, semaglutide and cagrilintide, are supplied as powders because that is the stable form for large acylated peptides in storage.

What is actually in Lipo-C?

Methionine, inositol and choline — the classic lipotropic trio — combined with cyanocobalamin, a form of vitamin B12, and L-carnitine. It is characterised by its formulation specification rather than by a single CAS number or molecular weight, since it is a mixture.

Does each component have a certificate of analysis?

The two peptide vials are released with lot-matched COAs reporting HPLC identity and purity. The Lipo-C solution is released against its own formulation specification rather than a single-peptide purity assay, since it is a compounded mixture.

Why pair a GLP-1 agonist with an amylin analogue?

They act through separate receptor families that reach overlapping brain regions. Semaglutide engages the GLP-1 receptor; cagrilintide acts at amylin and calcitonin receptor complexes. Research designs examining both arms need a molecule from each, held in separate vials.

How should the Lipo-C solution be stored?

Refrigerated at 2 to 8 degrees Celsius and protected from light. The cyanocobalamin component is light-sensitive, which is why these solutions are typically supplied in amber or otherwise shielded containers and should not be left out on a bench.

Related

Others in Weight Management Blends

View category